JYQ-164 is a small molecule inhibitor of Parkinsons disease protein 7 (PARK7/DJ-1) in humans. JYQ-164 works by covalently and selectively targeting Cys106, a key residue of PARK7 (IC50=21 nM). The high inhibitory effect of JYQ-164 on PARK7 is 5 times more potent than the previously reported inhibitor JYQ-88. JYQ-164 can be used in Parkinsons disease and cancer research[1].
Molecular Weight:
530.62
Purity:
99.43
Formula:
C23H26N6O5S2
Target:
PINK1/Parkin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
